Cooper/Norland
This article was originally published in The Gray Sheet
Executive Summary
Purchase price of $5 mil. for the bone densitometry business of Norland Medical Systems could reach $12 mil. based on its performance over the next three years, CooperSurgical states Feb. 28. The Norland unit includes the peripheral Discovery system for measurement at the forearm,Apollo DXA dual energy x-ray adsorptiometry system for heel use, and central DXA systems Excell and XR-46 for axial and full body scans. The women's health unit of Cooper Companies has distributed the devices in the U.S. since November 2000; the 2001 sales were about $8.5 mil. Norland now plans to focus on R&D for musculoskeletal diagnostics. The deal, expected to close by May, was announced Feb. 28, the same day Cooper completed its $97 mil. purchase of Biocompatibles' divested eye care business (1"The Gray Sheet" Jan. 21, 2002, p. 13). On Feb. 27, Cooper announced sales for its first fiscal quarter (ended Jan. 31) of $58.1 mil., up 16%. Net income advanced 49% to $9.4 mil...
You may also be interested in...
Biocompatibles Lens Unit Divestiture Could Ripen Firm For Abbott Purchase
Biocompatibles' divestiture of its Eye Care division to Cooper Companies converts the British firm into a pure-play entity in the coronary and drug-coated stent market
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.